TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”) is pleased to announce that it has successfully exported medical grade psilocybin mushrooms to Psilo Pharma Inc. (“Psilo Pharma”), from its federally licensed ISO22000 certified production facility in Southern Africa, through its research partner in Portugal (the “Research Partner”…


Previous articleNuminus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022
Next articleWhole-Body Effects of Psychedelics Part 3 – The Heart